iBio, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
iBio, Inc. is a biotechnology research company that applies AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer, and other hard-to-treat conditions. By integrating proprietary 3D modeling with its drug discovery platforms, the firm is building a pipeline of antibody therapies aimed at addressing significant unmet medical needs. The company describes itself as leveraging AI and computational biology to transform drug discovery and accelerate development toward precision medicine. Headquartered in San Diego, California, iBio employs between 51 and 200 people and reports revenue in the tens of millions of dollars. In 2026, leadership changes included Elizabeth Stoner joining the board and also serving as chief executive officer and chief scientific officer.